Supporting Read-across Using Biological Data
Overview
Authors
Affiliations
Read-across, i.e. filling toxicological data gaps by relating to similar chemicals, for which test data are available, is usually done based on chemical similarity. Besides structure and physico-chemical properties, however, biological similarity based on biological data adds extra strength to this process. In the context of developing Good Read-Across Practice guidance, a number of case studies were evaluated to demonstrate the use of biological data to enrich read-across. In the simplest case, chemically similar substances also show similar test results in relevant in vitro assays. This is a well-established method for the read-across of e.g. genotoxicity assays. Larger datasets of biological and toxicological properties of hundreds and thousands of substances become increasingly available enabling big data approaches in read-across studies. Several case studies using various big data sources are described in this paper. An example is given for the US EPA's ToxCast dataset allowing read-across for high quality uterotrophic assays for estrogenic endocrine disruption. Similarly, an example for REACH registration data enhancing read-across for acute toxicity studies is given. A different approach is taken using omics data to establish biological similarity: Examples are given for stem cell models in vitro and short-term repeated dose studies in rats in vivo to support read-across and category formation. These preliminary biological data-driven read-across studies highlight the road to the new generation of read-across approaches that can be applied in chemical safety assessment.
Rovida C, Muscarella M, Locatelli M Methods Mol Biol. 2024; 2834:89-111.
PMID: 39312161 DOI: 10.1007/978-1-0716-4003-6_4.
Mansouri K, Taylor K, Auerbach S, Ferguson S, Frawley R, Hsieh J Environ Health Perspect. 2024; 132(8):85002.
PMID: 39106156 PMC: 11302584. DOI: 10.1289/EHP14001.
New approach methodologies in human regulatory toxicology - Not if, but how and when!.
Schmeisser S, Miccoli A, von Bergen M, Berggren E, Braeuning A, Busch W Environ Int. 2023; 178:108082.
PMID: 37422975 PMC: 10858683. DOI: 10.1016/j.envint.2023.108082.
Tate T, Wambaugh J, Patlewicz G, Shah I Comput Toxicol. 2023; 19:1-12.
PMID: 37309449 PMC: 10259651. DOI: 10.1016/j.comtox.2021.100171.
Lizarraga L, Suter G, Lambert J, Patlewicz G, Zhao J, Dean J Regul Toxicol Pharmacol. 2022; 137:105293.
PMID: 36414101 PMC: 11880891. DOI: 10.1016/j.yrtph.2022.105293.